Hologic
HOLX · NASDAQ
Bulios Fair Price
$63.47
16.5% downside
Current Price
$76.01
According to Bulios Fair Price, HOLX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Hologic, Inc. (HOLX) is an American company operating in the field of medical technologies and diagnostic solutions. The company specializes in the development, manufacturing, and sale of innovative medical devices and diagnostic tests for women's health. Its products include mammography systems, devices for osteoporosis diagnosis, cytology and molecular diagnostic systems, among others. Hologic holds a strong market position in women's health and is known for its advanced technologies and high-quality diagnostic solutions. The company focuses on providing innovative tools and technologies that enable early detection and diagnosis of diseases, contributing to the improvement of patients' health outcomes. Investors seeking exposure to the healthcare sector and technologies for women's health may consider shares of Hologic, Inc. (HOLX) as an interesting investment opportunity.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini
Employees
7,063
Headquarters
Marlborough